The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref.RDRGR20250703006.Se busca de manera urgente socio industrial para fabricar un reactor solar fotocatalítico para la degradación de pesticidas en una propuesta PRIMA 2025 lista para su presentación.
A consortium is ready to submit a proposal under the PRIMA 2025 call, Thematic Area 2-Farming systems in the Nexus, TOPIC: 1.2.1-2025. The aim is to develop a system that will treat pesticide-contaminated agricultural drainage water to enable safe reuse for...
Jul 4, 2025